(2023)
Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast Cancer.
JOURNAL OF BREAST CANCER.
26,
6
(2023)
The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer.
CANCERS.
15,
22
(2023)
The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis.
CANCERS.
15,
22
(2023)
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.
24,
21
(2023)
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer.
BREAST.
72,
(2023)
Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer.
CANCERS.
15,
19
(2023)
Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy.
WORLD JOURNAL OF CLINICAL CASES.
11,
27
(2023)
Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis.
JMIR PUBLIC HEALTH AND SURVEILLANCE.
9,
1
(2023)
Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer.
EXPERIMENTAL AND MOLECULAR MEDICINE.
55,
7
(2023)
Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study.
CANCERS.
15,
13
(2023)
Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study.
ANNALS OF SURGICAL TREATMENT AND RESEARCH.
105,
1
(2023)
Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer.
CANCERS.
15,
9
(2023)
Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients' Returning to Work (START): A Multi-center, Randomized Controlled Trial.
CANCER RESEARCH AND TREATMENT.
55,
2
(2023)
Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level.
JOURNAL OF BREAST CANCER.
26,
2
(2023)
Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis.
CANCERS.
15,
5
(2023)
Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells.
BIOMEDICINES.
11,
3
(2023)
The use of absorbable skin stapler in mastectomy does not increase the rate of surgical site infection.
ANNALS OF SURGICAL TREATMENT AND RESEARCH.
104,
3
(2023)
The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY.
15,
단행본
(2011)
Handbook of Surgery.
군자출판사.
공동
(2007)
Chassin 외과수술의 원칙과 실제.
가본의학.
공동
(1999)
유방학.
일조각.
공동
학술회의논문
(2105)
Comparisons of anxiety and depression between premenopausal women who received tamoxifen and goserelin versus tamoxifen alone to manage breast cancer : A 12-month prospective randomized study.
Annual Congress of KSS2015.
대한민국
(2023)
유방암 및 갑상선암 치료 전략의 최신 지견.
..
대한민국
(2019)
Epidermal growth factor receptor as therapeutic target in hormone receptor-positive breast cancer.
SABCS2019.
미국
(2019)
Impact of chemotherapy and radiotherapy on tissue expander or implant removal in the patients who received mastectomy and immediate breast reconstruction.
SABCS2019.
미국
(2019)
Risk of ipsilateral breast tumor recurrence in ductal carcinoma in situ following breast conserving surgery.
SABCS2019.
미국
(2019)
The clinical significance of EGFR(+) and HER2(+) breast cancer and interaction with tumor associated macrophages.
SABCS2019.
미국
(2019)
Protein-protein interaction of HER2 predicts the prognosis of hormone receptor-positive HER2-negative breast cancer.
SABCS2019.
미국
(2019)
Low estrogen receptor positive (1-10%) breast cancer prevalence, treatment patterns and prognosis: A single institution’s experience in Korea.
SABCS2019.
미국
(2019)
Radiologic complete response after neoadjuvant chemotherapy in advanced breast cancer can predict survival outcome, but not pathologic complete response.
SABCS2019.
미국
(2019)
The 5-years conditional disease free survival and overall survival for breast cancer patients in Korea.
SABCS2019.
미국
(2019)
Serum protein expression predicts neoadjuvant chemotherapy response in patients with locally advanced breast cancer.
SABCS2019.
미국
(2019)
A MULTI-CENTER, OPEN-LABEL, PARALLEL, PHASE 2
CLINICAL TRIAL TO EVALUATE THE EFFICACY AND
SAFETY OF LUMINOMARKTM (INDOCYANINE GREEN
0.01MG +HYALURONIC ACID SODIUM 4MG/2ML) FOR
LOCALIZATION IN PATIENTS.
GBCC2019.
대한민국
(2019)
A NEW DEVELOPED PREDICTED PROGNOSTIC SCORE
(GENESWELLTM BCT) AS A PREDICTOR OF RISK OF
RECURRENCE IN HR+/HER2- EARLY BREAST CANCER
IRRESPECTIVE OF AGE.
GBCC2019.
대한민국
(2019)
A PREDICTIVE MODEL FOR PATHOLOGIC COMPLETE
RESPONSE IN BREAST CANCER PATIENTS TREATED
WITH NEOADJUVANT CHEMOTHERAPY USING
MACHINE LEARNING.
GBCC2019.
대한민국
(2019)
BASAL AND IL-1β-INDUCED IL-8 IS SUPPRESSED BY
CELASTROL IN TRIPLE NEGATIVE BREAST CANCER.
GBCC2019.
대한민국
(2019)
CCL2 DERIVED FROM EGFR AND HER2(+) BREAST
CANCER CELLS RECRUITS TUMOR ASSOCIATED
MACROPHAGES.
GBCC2019.
대한민국
(2019)
CLINICAL OUTCOMES AFTER LETROZOLE TREATMENT
ACCORDING TO THE ESTROGEN RECEPTOR
EXPRESSION IN POSTMENOPAUSAL WOMEN: LETTER
TRIAL (KBCSG-006).
GBCC2019.
대한민국
(2019)
EFFECT OF POLOXAMER-BASED THERMO-SENSITIVE
SOL-GEL ON SHOULDER MOTION AFTER AXILLARY
LYMPH NODE DISSECTION IN PATIENTS WITH BREAST
CANCER: A MULTI-CENTER DOUBLE-BLIND,
RANDOMIZED CONTROLLED TRIAL.
GBCC2019.
대한민국
(2019)
PHASE II RANDOMIZED STUDY OF NEOADJUVANT
METFORMIN PLUS LETROZOLE VERSUS PLACEBO PLUS
LETROZOLE FOR ER-POSITIVE POSTMENOPAUSAL
BREAST CANCER [METEOR STUDY].
GBCC2019.
대한민국
(2019)
THE EFFECT OF ADJUVANT CHEMOTHERAPY ON
SURVIVAL IN KOREAN PATIENTS WITH NODE NEGATIVE
T1C, TRIPLE NEGATIVE BREAST CANCER.
GBCC2019.
대한민국
